Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · Real-Time Price · USD

0.3400

0.00 (0.00%)

At close: May 12, 2025, 4:00 PM

0.3400

-0.0001 (-0.01%)

After-hours: May 12, 2025, 7:59 PM EDT

Aptevo Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	-	-	3.11	12.29	4.31	Upgrade
Revenue Growth (YoY)	-	-	-74.67%	185.26%	-	Upgrade
Cost of Revenue	-	-	17.88	18.99	17.85	Upgrade
Gross Profit	-	-	-14.77	-6.7	-13.54	Upgrade
Selling, General & Admin	10.22	11.77	13.87	14.7	13.95	Upgrade
Research & Development	14.38	17.11	-	-	-	Upgrade
Operating Expenses	24.6	28.88	13.87	14.7	13.95	Upgrade
Operating Income	-24.6	-28.88	-28.64	-21.4	-27.49	Upgrade
Other Non Operating Income (Expenses)	0.47	0.58	-1.53	-8.01	-1.33	Upgrade
EBT Excluding Unusual Items	-24.13	-28.3	-30.17	-29.41	-28.82	Upgrade
Gain (Loss) on Sale of Assets	-	9.65	-	-	-	Upgrade
Other Unusual Items	-	-	37.18	-	-2.1	Upgrade
Pretax Income	-24.13	-18.65	7.01	-29.41	-30.92	Upgrade
Earnings From Continuing Operations	-24.13	-18.65	7.01	-29.41	-30.92	Upgrade
Earnings From Discontinued Operations	-	1.24	1.01	0.95	13.17	Upgrade
Net Income	-24.13	-17.41	8.03	-28.46	-17.75	Upgrade
Net Income to Common	-24.13	-17.41	8.03	-28.46	-17.75	Upgrade
Shares Outstanding (Basic)	0	-	-	-	-	Upgrade
Shares Outstanding (Diluted)	0	-	-	-	-	Upgrade
EPS (Basic)	-87.38	-	-	-	-	Upgrade
EPS (Diluted)	-87.38	-	-	-	-	Upgrade
Free Cash Flow	-23.79	-11.73	-21.05	-22.39	-29.41	Upgrade
Free Cash Flow Per Share	-86.14	-	-	-	-	Upgrade
Gross Margin	-	-	-	-54.52%	-	Upgrade
Operating Margin	-	-	-919.75%	-174.10%	-638.06%	Upgrade
Profit Margin	-	-	257.77%	-231.51%	-411.93%	Upgrade
Free Cash Flow Margin	-	-	-676.01%	-182.17%	-682.43%	Upgrade
EBITDA	-24.25	-28.31	-27.74	-20.26	-26.19	Upgrade
EBITDA Margin	-	-	-	-164.79%	-	Upgrade
D&A For EBITDA	0.35	0.57	0.9	1.14	1.31	Upgrade
EBIT	-24.6	-28.88	-28.64	-21.4	-27.49	Upgrade
EBIT Margin	-	-	-	-174.10%	-	Upgrade

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q